Daiwa Securities Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Buy |
3,173
+553
| +21% | +$1.39K | ﹤0.01% | 1126 |
|
|
2025
Q1 | $8K | Hold |
2,620
| – | – | ﹤0.01% | 1105 |
|
|
2024
Q4 | $7K | Hold |
2,620
| – | – | ﹤0.01% | 1146 |
|
|
2024
Q3 | $10K | Hold |
2,620
| – | – | ﹤0.01% | 1131 |
|
|
2024
Q2 | $17K | Sell |
2,620
-110
| -4% | -$714 | ﹤0.01% | 1132 |
|
|
2024
Q1 | $15K | Hold |
2,730
| – | – | ﹤0.01% | 1139 |
|
|
2023
Q4 | $14K | Buy |
2,730
+1,120
| +70% | +$5.74K | ﹤0.01% | 1141 |
|
|
2023
Q3 | $3K | Hold |
1,610
| – | – | ﹤0.01% | 1192 |
|
|
2023
Q2 | $4K | Hold |
1,610
| – | – | ﹤0.01% | 1189 |
|
|
2023
Q1 | $3K | Hold |
1,610
| – | – | ﹤0.01% | 1178 |
|
|
2022
Q4 | $8K | Buy |
1,610
+127
| +9% | +$631 | ﹤0.01% | 1118 |
|
|
2022
Q3 | $7K | Sell |
1,483
-24,106
| -94% | -$114K | ﹤0.01% | 1137 |
|
|
2022
Q2 | $95K | Buy |
25,589
+3,157
| +14% | +$11.7K | ﹤0.01% | 1025 |
|
|
2022
Q1 | $126K | Buy |
22,432
+6,676
| +42% | +$37.5K | ﹤0.01% | 1013 |
|
|
2021
Q4 | $96K | Buy |
15,756
+9,936
| +171% | +$60.5K | ﹤0.01% | 1009 |
|
|
2021
Q3 | $57K | Buy |
5,820
+5,074
| +680% | +$49.7K | ﹤0.01% | 1037 |
|
|
2021
Q2 | $11K | Buy |
746
+530
| +245% | +$7.82K | ﹤0.01% | 1038 |
|
|
2021
Q1 | $5K | Buy |
216
+12
| +6% | +$278 | ﹤0.01% | 1074 |
|
|
2020
Q4 | $3K | Buy |
+204
| New | +$3K | ﹤0.01% | 1081 |
|
|
2018
Q4 | – | Sell |
-439
| Closed | -$2K | – | 1145 |
|
|
2018
Q3 | $2K | Hold |
439
| – | – | ﹤0.01% | 1110 |
|
|
2018
Q2 | $1K | Hold |
439
| – | – | ﹤0.01% | 1152 |
|
|
2018
Q1 | $2K | Buy |
+439
| New | +$2K | ﹤0.01% | 1115 |
|